5 assets in Large-Cell Immunoblastic Lymphoma

Therapeutic assets addressing Large-Cell Immunoblastic Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
cd146/her2 car-t cells Large-Cell Immunoblastic Lymphoma	Essen Biotech	P1/2	CCC (48)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Large-Cell Immunoblastic Lymphoma	City of Hope Medical Center	P1	CC (43)